Utilization of oncotype DX in node-negative, ER-positive breast cancer patients

被引：0
|
作者：
Patel, H. [1 ]
Hook, K. [1 ]
Kaplan, C. [1 ]
Davidson, R. [1 ]
DeMichele, A. [1 ]
Fox, K. R. [1 ]
Domchek, S. M. [1 ]
机构：
[1] Abramson Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11067
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A Perimenopausal Woman With a Small, ER/HER2-Positive, Node-Negative Breast Cancer
    Brooks, Gabriel
    Borges, Virginia
    Singh, Meenakshi
    Rabinovitch, Rachel
    Finlayson, Christina
    Elias, Anthony
    ONCOLOGY-NEW YORK, 2008, 22 (11): : 1270 - 1276
  • [42] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    Jordan, VC
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S4 - S4
  • [43] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    VC Jordan
    Breast Cancer Research, 7
  • [44] 25-year survival and benefit from tamoxifen therapy by the clinically used breast cancer markers in lymph node-negative and ER-positive/HER2-negative breast cancer
    Dar, H. A.
    Johansson, A.
    Nordenskoljd, A.
    Iftimi, A.
    Yau, C.
    Perez-Tenorio, G.
    Benz, C.
    Nordenskjold, B.
    Stal, O.
    Esserman, L.
    Fornander, T.
    Lindstrom, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S23 - S23
  • [45] The Utility of Oncotype DX for Adjuvant Chemotherapy Treatment Decisions in Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative, Node-negative Breast Cancer
    Rizki, Hirah
    Hillyar, Christopher
    Abbassi, Omar
    Miles-Dua, Sascha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (03)
  • [46] Prognostic value of the 21-gene recurrence score in ER-positive,HER2-negative, node-positive breast cancer was similar in node-negative diseases: a single-center study of 800 patients
    Jiayi Wu
    Weiqi Gao
    Xiaosong Chen
    Chunxiao Fei
    Lin Lin
    Weiguo Chen
    Ou Huang
    Siji Zhu
    Jianrong He
    Yafen Li
    Li Zhu
    Kunwei Shen
    Frontiers of Medicine, 2021, 15 (04) : 621 - 628
  • [47] Prognostic value of the 21-gene recurrence score in ER-positive, HER2-negative, node-positive breast cancer was similar in node-negative diseases: a single-center study of 800 patients
    Jiayi Wu
    Weiqi Gao
    Xiaosong Chen
    Chunxiao Fei
    Lin Lin
    Weiguo Chen
    Ou Huang
    Siji Zhu
    Jianrong He
    Yafen Li
    Li Zhu
    Kunwei Shen
    Frontiers of Medicine, 2021, 15 : 621 - 628
  • [48] Evaluation of Oncotype DX Recurrence Score as a prognostic factor in Japanese women with estrogen receptor-positive, node-negative primary Stage I or IIA breast cancer
    Kyoko Yorozuya
    Toru Takeuchi
    Miwa Yoshida
    Yukako Mouri
    Junko Kousaka
    Kimihito Fujii
    Shogo Nakano
    Takashi Fukutomi
    Kazuo Hara
    Shu Ichihara
    Yingsong Lin
    Shogo Kikuchi
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 939 - 944
  • [49] Prognostic value of the 21-gene recurrence score in ER-positive, HER2-negative, node-positive breast cancer was similar in node-negative diseases: a single-center study of 800 patients
    Wu, Jiayi
    Gao, Weiqi
    Chen, Xiaosong
    Fei, Chunxiao
    Lin, Lin
    Chen, Weiguo
    Huang, Ou
    Zhu, Siji
    He, Jianrong
    Li, Yafen
    Zhu, Li
    Shen, Kunwei
    FRONTIERS OF MEDICINE, 2021, 15 (04) : 621 - 628
  • [50] Evaluation of Oncotype DX Recurrence Score as a prognostic factor in Japanese women with estrogen receptor-positive, node-negative primary Stage I or IIA breast cancer
    Yorozuya, Kyoko
    Takeuchi, Toru
    Yoshida, Miwa
    Mouri, Yukako
    Kousaka, Junko
    Fujii, Kimihito
    Nakano, Shogo
    Fukutomi, Takashi
    Hara, Kazuo
    Ichihara, Shu
    Lin, Yingsong
    Kikuchi, Shogo
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (06) : 939 - 944
12345